Barr PM - Search Results

1

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.

Barr PM, Saylors GB, Spurgeon SE, Cheson BD, Greenwald DR, O'Brien SM, Liem AK, Mclntyre RE, Joshi A, Abella-Dominicis E, Hawkins MJ, Reddy A, Di Paolo J, Lee H, He J, Hu J, Dreiling LK, Friedberg JW. Barr PM, et al. Blood. 2016 May 19;127(20):2411-5. doi: 10.1182/blood-2015-12-683516. Epub 2016 Mar 11. Blood. 2016. PMID: 26968534 Free PMC article. Clinical Trial.

2

The role of bortezomib in the treatment of lymphoma.

Barr P, Fisher R, Friedberg J. Barr P, et al. Cancer Invest. 2007 Dec;25(8):766-75. doi: 10.1080/07357900701579570. Cancer Invest. 2007. PMID: 18058474 Review.

3

Getting to the heart of the problem in treating diffuse large B-cell lymphoma.

Barr PM, Friedberg JW. Barr PM, et al. Leuk Lymphoma. 2011 Jul;52(7):1166-7. doi: 10.3109/10428194.2011.577260. Epub 2011 May 25. Leuk Lymphoma. 2011. PMID: 21612382 No abstract available.

4

Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.

Carter SJ, Bernstein SH, Friedberg JW, Barr PM. Carter SJ, et al. Among authors: barr pm. Leuk Res. 2011 Nov;35(11):e223-4. doi: 10.1016/j.leukres.2011.07.014. Epub 2011 Aug 6. Leuk Res. 2011. PMID: 21824654 No abstract available.

5

Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion.

Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung J, Sanz I, Friedberg JW. Barr PM, et al. Clin Immunol. 2012 Mar;142(3):237-42. doi: 10.1016/j.clim.2011.12.012. Epub 2012 Jan 5. Clin Immunol. 2012. PMID: 22284392 Free PMC article.

6

Novel agents in mantle cell lymphoma.

Noel MS, Friedberg JW, Barr PM. Noel MS, et al. Among authors: barr pm. Best Pract Res Clin Haematol. 2012 Jun;25(2):191-200. doi: 10.1016/j.beha.2012.04.001. Epub 2012 Apr 30. Best Pract Res Clin Haematol. 2012. PMID: 22687455 Free PMC article. Review.

7

Fostamatinib inhibits B-cell receptor signaling, cellular activation and tumor proliferation in patients with relapsed and refractory chronic lymphocytic leukemia.

Herman SE, Barr PM, McAuley EM, Liu D, Wiestner A, Friedberg JW. Herman SE, et al. Among authors: barr pm. Leukemia. 2013 Aug;27(8):1769-73. doi: 10.1038/leu.2013.37. Epub 2013 Feb 6. Leukemia. 2013. PMID: 23385377 Free PMC article. No abstract available.

8

Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma.

Hutchinson K, Jahangiri S, Calvi LM, Barr P, Friedberg JW, Kelly JL. Hutchinson K, et al. Leuk Lymphoma. 2015 Feb;56(2):508-11. doi: 10.3109/10428194.2014.919633. Epub 2014 Jul 15. Leuk Lymphoma. 2015. PMID: 24794808 No abstract available.

9

Emerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma.

Jahangiri S, Friedberg J, Barr P. Jahangiri S, et al. Expert Opin Emerg Drugs. 2014 Sep;19(3):367-83. doi: 10.1517/14728214.2014.929663. Epub 2014 Jun 24. Expert Opin Emerg Drugs. 2014. PMID: 24960458 Review.

10

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.

Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM. Barr PM, et al. Blood. 2014 Aug 21;124(8):1259-65. doi: 10.1182/blood-2014-04-570044. Epub 2014 Jul 11. Blood. 2014. PMID: 25016003 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page